ArticleOncoimmunology2012

Efficacy and toxicity of a CD22-targeted antibody-saporin conjugate in a xenograft model of non-Hodgkin's lymphoma.

Jason Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.